Skip to main content
Top
Published in: European Radiology 5/2011

01-05-2011 | Gastrointestinal

Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer

Authors: Seung Ho Kim, Jae Young Lee, Jeong Min Lee, Joon Koo Han, Byung Ihn Choi

Published in: European Radiology | Issue 5/2011

Login to get access

Abstract

Objective

To determine whether change in the apparent diffusion coefficient (ADC) before and after neoadjuvant chemoradiation therapy (CRT) for locally advanced rectal cancer (LARC) would more accurately predict pathological complete response (pCR) than analysing the pre- or post-CRT ADC individually.

Methods

76 patients with LARC (≥T3 or lymph node-positive) underwent pre- and post-CRT, 1.5-T diffusion-weighted imaging. A blinded radiologist measured the tumour ADCs. The three measures were compared with regard to CR and non-CR. To calculate accuracy for determining pCR, receiver-operating characteristic curve (ROC) analysis was applied to the three measures.

Results

The post-CRT ADC (1.43 ± 0.10) (×10−3 mm2/s) and the percentage change (70.0 ± 23.5%) in the CR (n = 11) were significantly higher than those in the non-CR (n = 65) (1.14 ± 0.18, 30.2 ± 21.7%, respectively)(both, P < 0.0001). The pre-CRT ADC (0.85 ± 0.10) of the pCR did not differ significantly from that of the non-pCR (0.88 ± 0.14)(P = 0.4094). The post-CRT ADC showed comparable relative accuracy for determining pCR to that of the percentage change (P = 0.788). However, overall accuracy of the former (87%) was higher than that of the latter (75%) (P = 0.049).

Conclusion

Analyzing post-CRT ADC alone can reliably differentiate pCR from non-pCR in LARC
Literature
1.
go back to reference Janjan NA, Crane C, Feig BW et al (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107–112PubMedCrossRef Janjan NA, Crane C, Feig BW et al (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107–112PubMedCrossRef
2.
go back to reference Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664–674PubMedCrossRef Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664–674PubMedCrossRef
3.
go back to reference Theodoropoulos G, Wise WE, Padmanabhan A et al (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45:895–903PubMedCrossRef Theodoropoulos G, Wise WE, Padmanabhan A et al (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45:895–903PubMedCrossRef
4.
go back to reference Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298–304PubMedCrossRef Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298–304PubMedCrossRef
5.
go back to reference Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D (2005) Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:665–677PubMedCrossRef Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D (2005) Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:665–677PubMedCrossRef
6.
go back to reference Hartley A, Ho K, McConkey C et al (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78:934–938PubMedCrossRef Hartley A, Ho K, McConkey C et al (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78:934–938PubMedCrossRef
7.
go back to reference Stipa F, Chessin DB, Shia J et al (2006) A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieved no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 13:1047–1053PubMedCrossRef Stipa F, Chessin DB, Shia J et al (2006) A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieved no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 13:1047–1053PubMedCrossRef
8.
go back to reference Hughes R, Glynne-Jones R, Grainger J et al (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 21:11–17PubMedCrossRef Hughes R, Glynne-Jones R, Grainger J et al (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 21:11–17PubMedCrossRef
9.
go back to reference Byrd DR, Compton CC, Fritz AG, Trotti A III (2009) Colon and rectum. In: Edge SB (ed) AJCC Cancer Staging Manual, 7th edn. Springer, New York, pp 143–159 Byrd DR, Compton CC, Fritz AG, Trotti A III (2009) Colon and rectum. In: Edge SB (ed) AJCC Cancer Staging Manual, 7th edn. Springer, New York, pp 143–159
10.
go back to reference Maas M, Lambregts DMJ, Nelemans PJ, Beets GL, Beets-Tan RG (2010) Response after chemoradiation in rectal cancer is associated with improved long-term outcome: a pooled analysis (abstr). In: European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting Program. Dresden, Germany Maas M, Lambregts DMJ, Nelemans PJ, Beets GL, Beets-Tan RG (2010) Response after chemoradiation in rectal cancer is associated with improved long-term outcome: a pooled analysis (abstr). In: European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting Program. Dresden, Germany
11.
go back to reference Brown CL, Ternent CA, Thorson AG et al (2003) Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 46:1189–1193PubMedCrossRef Brown CL, Ternent CA, Thorson AG et al (2003) Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 46:1189–1193PubMedCrossRef
12.
go back to reference Bonnen M, Crane C, Vauthey J et al (2004) Long-term results using local excision after preoperative chemoradiation among selected T3 cancer patients. Int J Radiat Oncol Biol Phys 60:1098–1105PubMedCrossRef Bonnen M, Crane C, Vauthey J et al (2004) Long-term results using local excision after preoperative chemoradiation among selected T3 cancer patients. Int J Radiat Oncol Biol Phys 60:1098–1105PubMedCrossRef
13.
go back to reference Habr-Gama A, Perez R, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717PubMed Habr-Gama A, Perez R, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717PubMed
14.
go back to reference O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM (2007) Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 8:625–633PubMedCrossRef O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM (2007) Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 8:625–633PubMedCrossRef
15.
go back to reference Bujko K, Kepka L, Nowacki MP (2007) Chemoradiotherapy alone for rectal cancer: a word of caution. Lancet Oncol 8:860–862PubMedCrossRef Bujko K, Kepka L, Nowacki MP (2007) Chemoradiotherapy alone for rectal cancer: a word of caution. Lancet Oncol 8:860–862PubMedCrossRef
16.
go back to reference Den Dulk M, Van de Velde CJ (2007) Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol 8:570–571CrossRef Den Dulk M, Van de Velde CJ (2007) Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol 8:570–571CrossRef
17.
go back to reference Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T (2008) Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15:712–720PubMedCrossRef Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T (2008) Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15:712–720PubMedCrossRef
18.
go back to reference Koh DM, Padhani AR (2006) Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol 79:633–635PubMedCrossRef Koh DM, Padhani AR (2006) Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol 79:633–635PubMedCrossRef
19.
go back to reference Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635PubMedCrossRef Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635PubMedCrossRef
20.
go back to reference Patterson DM, Padhani AR, Collins DJ (2008) Technology insight: water diffusion MRI—a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 5:220–233PubMedCrossRef Patterson DM, Padhani AR, Collins DJ (2008) Technology insight: water diffusion MRI—a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 5:220–233PubMedCrossRef
21.
go back to reference Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMed Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMed
22.
go back to reference Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152PubMedCrossRef Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152PubMedCrossRef
23.
go back to reference Abdel Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N (2008) Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 49:364–370CrossRef Abdel Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N (2008) Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 49:364–370CrossRef
24.
go back to reference Dzik-Jurasz A, Domenig C, George M et al (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360:307–308PubMedCrossRef Dzik-Jurasz A, Domenig C, George M et al (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360:307–308PubMedCrossRef
25.
go back to reference Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A (2003) Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179:641–649PubMedCrossRef Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A (2003) Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179:641–649PubMedCrossRef
26.
go back to reference DeVries AF, Kremser C, Hein PA et al (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56:958–965PubMedCrossRef DeVries AF, Kremser C, Hein PA et al (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56:958–965PubMedCrossRef
27.
go back to reference Kim SH, Lee JM, Hong SH, Kim KH, Han JK, Choi BI (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 253:116–125PubMedCrossRef Kim SH, Lee JM, Hong SH, Kim KH, Han JK, Choi BI (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 253:116–125PubMedCrossRef
28.
go back to reference Hein PA, Kremser C, Judmaier W et al (2003) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222PubMedCrossRef Hein PA, Kremser C, Judmaier W et al (2003) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222PubMedCrossRef
29.
go back to reference Sun YS, Zhang XP, Tang L et al (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254:170–178PubMedCrossRef Sun YS, Zhang XP, Tang L et al (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254:170–178PubMedCrossRef
30.
go back to reference Greene FL, Page DL, Fleming ID et al (2002) Colon and rectum. In: Fritz AG (ed) AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 113–124CrossRef Greene FL, Page DL, Fleming ID et al (2002) Colon and rectum. In: Fritz AG (ed) AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 113–124CrossRef
31.
go back to reference Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23PubMedCrossRef Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23PubMedCrossRef
32.
go back to reference Kim YH, Kim DY, Kim TH et al (2005) Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62:761–768PubMedCrossRef Kim YH, Kim DY, Kim TH et al (2005) Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62:761–768PubMedCrossRef
33.
go back to reference Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI (2009) Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 29:1093–1101PubMedCrossRef Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI (2009) Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 29:1093–1101PubMedCrossRef
34.
go back to reference Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI (2008) Ultrasound transmission gel as an endorectal contrast agent for tumor visualization of rectal cancer. Am J Roentgenol 191:186–189CrossRef Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI (2008) Ultrasound transmission gel as an endorectal contrast agent for tumor visualization of rectal cancer. Am J Roentgenol 191:186–189CrossRef
35.
go back to reference Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI (2008) Diagnostic accuracy of 3.0-Tesla rectal magnetic resonance imaging in preoperative local staging of primary rectal cancer. Invest Radiol 43:587–593PubMedCrossRef Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI (2008) Diagnostic accuracy of 3.0-Tesla rectal magnetic resonance imaging in preoperative local staging of primary rectal cancer. Invest Radiol 43:587–593PubMedCrossRef
36.
go back to reference Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G (2009) MRI staging of low rectal cancer. Eur Radiol 19:643–650PubMedCrossRef Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G (2009) MRI staging of low rectal cancer. Eur Radiol 19:643–650PubMedCrossRef
37.
go back to reference Norman GR, Streiner DL et al (2003) PDQ Statistics, 3rd edn. Decker Inc, Hamilton, pp 91–92 Norman GR, Streiner DL et al (2003) PDQ Statistics, 3rd edn. Decker Inc, Hamilton, pp 91–92
38.
go back to reference Heo S, Jeong S, Young J et al (2010) A comparative study of histopathologic parameters and apparent diffusion coefficient values on 3T rectal MRI in locally advanced rectal cancer following neoadjuvant chemoradiation therapy (abstr). In: European Congress of Radiology (ECR) Annual Meeting Program. Vienna, Austria Heo S, Jeong S, Young J et al (2010) A comparative study of histopathologic parameters and apparent diffusion coefficient values on 3T rectal MRI in locally advanced rectal cancer following neoadjuvant chemoradiation therapy (abstr). In: European Congress of Radiology (ECR) Annual Meeting Program. Vienna, Austria
39.
go back to reference Barbaro B, Fiorucci C, Tebala C et al (2009) Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250:730–739PubMedCrossRef Barbaro B, Fiorucci C, Tebala C et al (2009) Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250:730–739PubMedCrossRef
40.
go back to reference Dresen RC, Beets GL, Rutten HJT et al (2009) Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy part I. are we able to predict tumor confined to the rectal wall? Radiology 252:71–80PubMedCrossRef Dresen RC, Beets GL, Rutten HJT et al (2009) Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy part I. are we able to predict tumor confined to the rectal wall? Radiology 252:71–80PubMedCrossRef
41.
go back to reference Denecke T, Rau B, Hoffmann KT et al (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15:1658–1666PubMedCrossRef Denecke T, Rau B, Hoffmann KT et al (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15:1658–1666PubMedCrossRef
Metadata
Title
Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer
Authors
Seung Ho Kim
Jae Young Lee
Jeong Min Lee
Joon Koo Han
Byung Ihn Choi
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
European Radiology / Issue 5/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1989-y

Other articles of this Issue 5/2011

European Radiology 5/2011 Go to the issue